The levels of serum albumin in low dose Noveliver group and high dose Noveliver group were inclined to be higher than that in compound protein pollen group in the second week of treatment, but the difference was not significant (P = 0.139, 0.297), which indicated that as a new liver nutrient, Noveliver may be the same as the compound protein pollen, even more advantageous in improving malnutrition. This evidence concerns the gene ALB and malnutrition.